These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 25881677

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study.
    Lipton RB, Dodick DW, Adelman JU, Kaniecki RG, Lener SE, White JD, Nelsen AC.
    Cephalalgia; 2009 Aug; 29(8):826-36. PubMed ID: 19220307
    [Abstract] [Full Text] [Related]

  • 3. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland PG, Shin P, Siffert J.
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine.
    Derosier FJ, Lewis D, Hershey AD, Winner PK, Pearlman E, Rothner AD, Linder SL, Goodman DK, Jimenez TB, Granberry WK, Runken MC.
    Pediatrics; 2012 Jun; 129(6):e1411-20. PubMed ID: 22585767
    [Abstract] [Full Text] [Related]

  • 9. Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
    Landy SH, Cady RK, Nelsen A, White J, Runken MC.
    Headache; 2014 Apr; 54(4):640-54. PubMed ID: 24102322
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A, Gennings C, Cady R.
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sumatriptan plus naproxen for acute migraine attacks in adults.
    Law S, Derry S, Moore RA.
    Cochrane Database Syst Rev; 2013 Oct 21; (10):CD008541. PubMed ID: 24142431
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Silberstein SD, Mannix LK, Goldstein J, Couch JR, Byrd SC, Ames MH, McDonald SA, Lener SE, Toso C.
    Neurology; 2008 Jul 08; 71(2):114-21. PubMed ID: 18606965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.